Has Maher Abu-Hamdan, MD received payments from drug or device companies?

Yes. Drug and device makers reported $10,935 in general payments to Maher Abu-Hamdan, MD across 273 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Maher Abu-Hamdan, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Maher Abu-Hamdan, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Maher Abu-Hamdan, MD

Otolaryngology · South Bend, INNPI 1144431503

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $7,503 of the $10,935 with a category attached, or 68.6%. 20 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 27.2% of the total. Among otolaryngology clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$10,935in general payments, 2019–2025

Across 273 payments — averaging $40.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Inspire Medical Systems, Inc.$3K
Intersect ENT, Inc.$2K
Stryker$2K
Medtronic$2K
Optinose US, Inc.$940
Sanofi$858
plus $1K from 14 others

What the payments were for

Travel & lodging$3,43331%
Food & beverage$7,50369%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Inspire Medical Systems, Inc.	57	$2,970
Intersect ENT, Inc.	13	$2,042
Stryker	33	$1,563
Medtronic	20	$1,534
Optinose US, Inc.	67	$940
Sanofi	32	$858
Regeneron Healthcare Solutions, Inc.	13	$303
GSK	18	$266
Aerin Medical Inc.	3	$180
Acclarent, Inc	2	$49
Genentech USA, Inc.	2	$36
Merck	2	$32
Zimmer Biomet	2	$29
Novartis	2	$29
Alk-abello, Inc	2	$27
Boston Scientific	1	$24
Olympus America Inc.	1	$15
Bolder Surgical, LLC	1	$15
Arbor Pharmaceuticals, Inc.	1	$13
Johnson & Johnson	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

SINUVA$1,728
PROPEL$1,728
Inspire$1,605
STEALTHSTATION S8 PLATFORM$1,091
XPRESS ENT DILATION SYSTEM$343
ENTELLUS - FIAGON SINUS NAVIGATION SYSTEM$256
ENTELLUS - XPRESS ENT DILATION SYSTEM$229
VIVAER STYLUS$130
RHINAER STYLUS$130
ENTELLUS - ENTELLUS MEDICAL SHAVER SYSTEM$123
DUPIXENT$123

How this compares

$10,935 in reported general payments places this provider in the 90th percentile of 193 otolaryngology providers in Indiana.

See all otolaryngology providers in Indiana →

Medicare billing

Part B allowed, 2024

$105,672

Medicare patients

346

Services billed

879

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ipratropium Bromide	205	$4,015
Budesonide	13	$2,809
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth	28	$2,745
Fluocinolone Acetonide Oil	30	$1,116
Azelastine Hcl	38	$588
Fluticasone Propionate	30	$488
Levothyroxine Sodium	42	$290
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	60	$218
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	15	$211
Mupirocin	25	$182
Amitriptyline Hcl	13	$175
Ondansetron Hcl	40	$108
Prednisone	22	$34

Paid to pharmacies, not to this prescriber.

Other otolaryngology in South Bend

Sonia YuenSouth Bend$9K
Michael PfeifferSouth Bend$9K
David IsaacsonSouth Bend$4K
Philip PersinoSouth Bend$4K
David SabatoSouth Bend$3K
Joshua GreeneAnderson$955K
Satyan SreenathIndianapolis$103K
Stephen FreemanCarmel$33K
Venkata KakarlapudiNew Albany$33K
Elisa IllingIndianapolis$28K

See the full list for Indiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →